Ranibizumab versus verteporfin for neovascular age-related macular degeneration. | NobleBlocks

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

Public

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

N

Shared by NobleBlocks on Oct 5, 2006 • 12:00 AM UTC

Authors:

David M. Brown

,

P. Kaiser

,

M. Michels

Subject

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!

Publication Date: Oct 5, 2006 • 12:00 AM UTC

DOI:10.1056/NEJMOA062655

No figures available

Scan for Errors

Scan for EDDII

Summarise

Generate Podcast